Diagnostics lag is holding back new therapies, says study
Advances in therapeutics are outpacing the development of diagnostics due to policy and payment barriers, holding back effective, targeted care.
Newsletters and Deep Dive digital magazine
Advances in therapeutics are outpacing the development of diagnostics due to policy and payment barriers, holding back effective, targeted care.
Gaps in support could undermine a wave of new independent prescribers entering the NHS and a push for more community-based care, warns a new report.
AbbVie has opened a new front in the pharma industry's efforts to reform the 340B drug discounting programme for safety net hospitals in the US.
Gene variants could explain why some people lose more weight than others with GLP-1 drugs, and why some are more prone to side effects.
A bid to limit access to the abortion pill mifepristone in the US, while the FDA carries out a review of the drug, has been blocked in the courts.
Editor's Picks
Newsletters and Deep Dive
digital magazine